Introduction
Renal cytochrome P450 (CYP)-dependent arachidonic acid metabolites have a wide and contrasting spectrum of biological effects. The pro®le and relative rates of eicosanoid production not only in¯uence renal haemodynamics and tubular ion and water transport but may also play a determinant role in mechanisms associated with the development of hypertension. The eicosanoids generally thought to play major roles in regulating these functions are the epoxyeicosatrienoic acids (EETs) and their derivatives which activate Ca 2q -dependent K q (K Ca ) channels in endothelial and smooth-muscle cells, as well as 20-hydroxyeicosatetraenoic acid (20-HETE) which exerts an antagonistic effect on K Ca channel activity. There are also reactive oxygen species (e.g. superoxide anions) generated during the enzymatic conversion of arachidonic acid by CYP within the vascular wall, which have both acute and chronic effects on vascular homeostasis.
NO, EDHF and the control of vascular tone
Nitric oxide (NO) and prostacyclin (PGI 2 ) are the best-characterized vasodilatory endothelium-derived autacoids; however, a third type of agonist-induced, endothelium-dependent relaxation can be evidenced in the presence of a combination of nitric oxide synthase and cyclo-oxygenase inhibitors. Since this NOuPGI 2 -independent relaxation was not observed in the presence of depolarizing concentrations of K q and was co-incident with vascular smooth-muscle hyperpolarization, the relaxation was assumed to be mediated by an endothelium-derived hyperpolarizing factor (EDHF). The relative importance of NO and EDHF in mediating endothelium-dependent vasodilatation alter on descending the vascular tree, such that EDHF becomes the predominant endothelium-derived modulator of arteriolar dilatation. Most resistancesized arteries are thought to be hybrids which express both the NO and the EDHF synthases. It is in these vessels that the loss of one vasodilator system can be compensated for by an increase in the output of the other (for review see w1x).
Although various EDHFs have been described in different vascular beds, there is compelling new evidence suggesting that the hyperpolarizing factor produced by coronary and renal arteries is a CYP epoxygenasederived metabolite of arachidonic acid. Indeed, inducing the expression of the CYP 2C epoxygenase in porcine coronary arteries increases the endothelial generation of 11,12-EET and enhances both the bradykinin-induced hyperpolarization and relaxation of vascular smooth-muscle cells w2x. Using an antisense approach to attenuate either the activity or the expression of the endothelial CYP 2C, on the other hand, attenuates all of the EDHF-mediated responses w2x. EDHFuEET-mediated relaxation is generally attributed to the activation of K Ca channels, although a role for EETs in the modulation of Cl À conductance cannot be ruled out.
Other actions of EETs
The role of EETuEDHF in the vasculature may well extend beyond its function as a vasodilator to the regulation of a number of genes in the vascular wall. Indeed, in endothelial and smooth-muscle cells, EETs can be incorporated into phospholipids and thus remain in the vascular wall long enough to produce chronic effects w3x. The exogenous application of EET to cultured or native endothelial cells decreases the activity of NF-kB and attenuates the TNF-a-induced 
Other CYP-derived products
The putative EDHF synthase (a CYP enzyme homologous to 2C9) is also a physiologically relevant source of reactive oxygen species, and its overexpression of CYP 2C9 in coronary artery endothelial cells markedly increases reactive oxygen species generation in addition to that of the EETs w6x. The consequences of superoxide anion anduor hydrogen peroxide production by CYP 2C9 range from the impairment of NO-mediated relaxation to a chronic elevation in the activity of the redox-sensitive transcription factor NF-kB and the expression of VCAM-1 w6x, i.e. the opposite of the effects observed following exogenous EET application. Thus, while the anti-in¯ammatory CYP product EDHFuEET may be the dominant endothelium-derived vasoactive autacoid in states associated with a manifest endothelial dysfunction', the enhanced activation of the CYP-like EDHF synthase may be detrimental to vascular homeostasis, as a consequence of the simultaneous generation of EETs and reactive oxygen species. It is also possible that lipid peroxides generated during the CYP reaction are able to scavenge NO in much the same way as described for 15-lipoxygenase and prostaglandin H synthase w7x.
20-HETE and its interaction with NO
Of the CYP isoforms identi®ed to date in the kidney, most generate 20-HETE when incubated with arachidonic acid. A few EET-generating enzymes (from the 2A, 2E, 2C, and 2J families) have been detected but it is likely that different CYP isoforms generate different EET pro®les in different parts of the kidney. 20-HETE which is endogenously produced by smooth-muscle cells from small renal and cerebral vessels, is thought to be involved in the development of myogenic tone, since it increases smooth-muscle tone by inhibiting large conductance K Ca channels, inducing depolarization, and increasing wCa 2q x i , probably by activating L-type Ca 2q channels w8x. NO may also modulate the formation of 20-HETE by binding and inactivating the CYP haem moiety in much the same way that it inhibits EDHF synthase.
20-HETE is also involved in the regulation of sodium transport. The mechanism underlying this effects is thought to be a 20-HETE-induced activation of protein kinase C, which phosphorylates the a-subunit of the Na-K-ATPase, thus inhibiting its activity. Intrarenal infusion of an inhibitor of 20-HETE and EET production in rats induced diuresis and natriuresis, which are associated with an increase in renal papillary blood ow.
Soluble epoxide hydrolase and hypertension
While EETs are potent vasodilators and exert antiin¯ammatory properties w4x, there is evidence suggesting that CYP expression, EETs, dihydroxyeicosatrienoic acid (DHET), and 20 HETE generation are increased in hypertension w9x. Notably, there is a marked increase in the renal metabolism of EET to DHET, suggesting that either the activity or the expression of the soluble epoxide hydrolase (sEH) increases during the development of hypertension w9x. Indeed, the sEH has recently been suggested to play a key role in hypertension, based on the ®ndings that:
(i) deletion of the soluble epoxide hydrolase gene lowered systolic blood pressure and altered arachidonic acid metabolism in male mice w10x; (ii) an sEH inhibitor decreased DHET formation and markedly reduced blood pressure in adult spontaneously hypertensive rats (SHR) w11x; and (iii) the expression of sEH was markedly higher in renal microsomes from genetically hypertensive animals than from Wistar rats w11x.
However, the expression of sEH, unlike the generation of EET, was elevated in SHR from birth and was not a phenomenon that could be directly correlated to the age of the animals or, more importantly, to the development of overt hypertension. The`DHETinduced hypertension' hypothesis moreover assumes that elevated concentrations of EETs are bene®cial, while elevations in DHET are detrimental. Currently no experimental evidence exists to support this, and although the vascular response of DHET varies markedly with the vessel studied, DHET is a potent vasodilator in the coronary circulation w12x. One possibility, yet to be addressed is that there may be a gradual switch-over of the substrate metabolized by the CYP enzymes in the kidney. For example, renal CYPs of the 2C and 2J families also metabolize linoleic acid to epoxyoctadecenoic acid and its derivatives w13x and several studies have suggested an sEH-dependent pathway for the nephrotoxicity induced by 9,10-and 12,13-epoxyoctadecenoic acid w14±16x. Although a direct relationship between enhanced linoleic acid metabolism by CYPs and the development of hypertension is speculative, a diet high in linoleic acid potentiates hypertension in the Dahl salt-sensitive rat w17x, suggesting that CYP derivatives other than the EETs might be important in the genesis of some forms of hypertension.
